{"type":"video","version":"1.0","html":"<iframe width=\"560\" height=\"315\" sandbox=\"allow-same-origin allow-scripts allow-popups allow-forms\" title=\"Dual-Targeting Gemcitabine-Resistant Pancreatic Cancer with Novel Engineered Nanobody\" src=\"https://video.igem.org/videos/embed/gaVKyEU462H2u1qAotGeis\" style=\"border: none\" allow=\"fullscreen\"></iframe>","width":560,"height":315,"title":"Dual-Targeting Gemcitabine-Resistant Pancreatic Cancer with Novel Engineered Nanobody","author_name":"2024 Live Stage Talks","author_url":"https://video.igem.org/video-channels/2024_live_stage_talks","provider_name":"PeerTube","provider_url":"https://video.igem.org","thumbnail_url":"https://video.igem.org/lazy-static/thumbnails/1be7edae-54d7-4ba6-80fe-d0c5c63b9296.jpg","thumbnail_width":850,"thumbnail_height":480}